Pandemic Influenza

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-12-17
EMA Authorised: Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) (split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)) — GlaxoSmithKline Biologicals S.A.
EMA authorised Adjupanrix, a split-virion inactivated adjuvanted influenza vaccine for pandemic influenza (H5N1) using the A/VietNam/1194/20…